Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharada Mokkapati

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Anticancer Therapy|April 13, 2023
The current status of gene therapy in bladder cancerCôme Tholomier, Alberto Martini, Sharada Mokkapati, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 21, 2012
Absence of the basement membrane component nidogen 2, but not of nidogen 1, results in increased lung metastasis in miceSharada Mokkapati, Manuela Bechtel, Marion Reibetanz, et al.
Frontiers in Immunology|September 14, 2023
Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approvalAlberto Martini, Côme Tholomier, Sharada Mokkapati, et al.
Apoptosis : an International Journal on Programmed Cell Death|September 22, 2016
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacksGoodwin G Jinesh, Sharada Mokkapati, Keyi Zhu, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
The Evolution of Nadofaragene Firadenovec: A Review and the Path ForwardAlexis R Steinmetz, Sharada Mokkapati, David McConkey, et al.
Microscopy Research and Technique|January 26, 2008
Nidogens-Extracellular matrix linker moleculesMatthew S P Ho, Kerstin Böse, Sharada Mokkapati, et al.
The Journal of Investigative Dermatology|March 22, 2008
Basement membranes in skin are differently affected by lack of nidogen 1 and 2Sharada Mokkapati, Anke Baranowsky, Nicolae Mirancea, et al.
Genesis (New York, N.Y. : 2000)|September 13, 2019
Generation of a novel mouse strain with conditional, cell-type specific, expression of DND1Lisa Nunez, Sharada Mokkapati, Chengtai Yu, et al.
Neoplasia (New York, N.Y.)|March 4, 2016
Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 UpregulationLe Huang, Sharada Mokkapati, Qianghua Hu, et al.
Expert Opinion on Biological Therapy|January 8, 2025
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancerAlexis R Steinmetz, Behzad Jazayeri, Morgan Pierce, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Anticancer Therapy|April 13, 2023
The current status of gene therapy in bladder cancerCôme Tholomier, Alberto Martini, Sharada Mokkapati, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 21, 2012
Absence of the basement membrane component nidogen 2, but not of nidogen 1, results in increased lung metastasis in miceSharada Mokkapati, Manuela Bechtel, Marion Reibetanz, et al.
Frontiers in Immunology|September 14, 2023
Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approvalAlberto Martini, Côme Tholomier, Sharada Mokkapati, et al.
Apoptosis : an International Journal on Programmed Cell Death|September 22, 2016
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacksGoodwin G Jinesh, Sharada Mokkapati, Keyi Zhu, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
The Evolution of Nadofaragene Firadenovec: A Review and the Path ForwardAlexis R Steinmetz, Sharada Mokkapati, David McConkey, et al.
Microscopy Research and Technique|January 26, 2008
Nidogens-Extracellular matrix linker moleculesMatthew S P Ho, Kerstin Böse, Sharada Mokkapati, et al.
The Journal of Investigative Dermatology|March 22, 2008
Basement membranes in skin are differently affected by lack of nidogen 1 and 2Sharada Mokkapati, Anke Baranowsky, Nicolae Mirancea, et al.
Genesis (New York, N.Y. : 2000)|September 13, 2019
Generation of a novel mouse strain with conditional, cell-type specific, expression of DND1Lisa Nunez, Sharada Mokkapati, Chengtai Yu, et al.
Neoplasia (New York, N.Y.)|March 4, 2016
Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 UpregulationLe Huang, Sharada Mokkapati, Qianghua Hu, et al.
Expert Opinion on Biological Therapy|January 8, 2025
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancerAlexis R Steinmetz, Behzad Jazayeri, Morgan Pierce, et al.
Pageof 3